trending Market Intelligence /marketintelligence/en/news-insights/trending/Tvye0Pk89JxrG9cQufqPUQ2 content esgSubNav
In This List

Dimension Therapeutics adds director

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Dimension Therapeutics adds director

Dimension Therapeutics Inc. appointed John Hohneker, an executive vice president and head of research and development at FORMA Therapeutics Inc., to its board of directors, effective Jan. 18.

Hohneker will serve as a class 1 director until Dimension's next annual stockholders' meeting following Dec. 31, 2018.